GLIOTENZIDE 20 TABLET
Product details
Registration number: SIN12641P
Classification: Prescription Only
Active ingredients:
- ENALAPRIL MALEATE USP
- HYDROCHLOROTHIAZIDE USP
Strength:
- 20 mg
- 12.5 mg
Dosage form: TABLET
Route: ORAL
Registrant: ZYFAS PHARMA PTE LTD
ATC code: C09BA02
HSA approval date: 14 January 2005
Manufacturer(s): LABORATORIOS BAGO SA
Manufacturing country/countries: ARGENTINA
What are the HSA registration number and classification for GLIOTENZIDE 20 TABLET?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12641P
Classification: Prescription Only
What active ingredients and strength are recorded for GLIOTENZIDE 20 TABLET?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- ENALAPRIL MALEATE USP
- HYDROCHLOROTHIAZIDE USP
Strength:
- 20 mg
- 12.5 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for GLIOTENZIDE 20 TABLET?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET
Route: ORAL
Who is the recorded registrant for GLIOTENZIDE 20 TABLET?
According to the HSA dataset updated 7 August 2026:
Registrant: ZYFAS PHARMA PTE LTD
Which manufacturers and countries are listed for GLIOTENZIDE 20 TABLET?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): LABORATORIOS BAGO SA
Manufacturing country/countries: ARGENTINA
Where can I look up GLIOTENZIDE 20 TABLET in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12641P or the exact product name GLIOTENZIDE 20 TABLET. The general register link does not preselect this product.
What are the source dates for this GLIOTENZIDE 20 TABLET record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this GLIOTENZIDE 20 TABLET record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12641P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)